Infectious Diseases 1004 - Infectious Disease Alert - Apr 01, 2006

Target Audience:

This activity is intended for the infectious disease specialist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Associate Editors
Jessica Song, PharmD
Assistant Professor of Pharmacy Practice
University of the Pacific
Stockton, CA
Pharmacy Clerkship and Coordinator
Santa Clara Valley Medical Center
Section Editor, Managed Care

Dean L. Winslow, MD, FACP
Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV

Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases;
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Rick Ngo
PharmD Candidate
University of the Pacific

Jarrod Mills
PharmD Candidate
University of the Pacific

Paul Hsiao
PharmD Candidate
Clinical Pharmacist Specialist
Santa Clara Valley Medical Center


  • Treating Invasive Candidiasis: Sooner (Much Sooner) is Better
  • Expanding the Echinocandin Class: Eraxis® (Anidulafungin)
  • Host Genetics, Coreceptor Function, Host Susceptibility to HIV Infection, and Disease Progression
  • Updates


  • To discuss diagnosis and treatment of infectious diseases
  • To present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • To present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • To discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new thera

Financial Disclosure:

Infectious Disease Alert’s Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Associate Editor, Dean L. Winslow, MD, FACP is a consultant for Bayer Diagnostics and Pfizer/Agouron, and is on the speaker’s bureau for Pfizer/Agouron.

Associate Editor, Carol Kempner, MD, reports that she is on the speaker’s bureau for Pfizer, GlaxoSmithKline, and Agouron and does research for Agouron, GlaxoSmithKline, and Beecham Pharmaceuticals.

Peer Reviewer, Connie Price, MD, Associate Editor, Jessica C. Song, MA, PharmD, and Authors, Rick Ngo, Jarrod Mills, and Paul Hsiao report no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company related to this field of study.

Copyright 2006 AHC Media. All rights reserved.